Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
While appendectomy has been the main treatment of appendicitis for over 100 years, recent European studies found that, at least among highly selected patients, antibiotics alone can be an effective alternative. Surgeons and patients alike have a difficult time deciding if surgery or antibiotics are the best choice to treat appendicitis. The goal of the TRIAD is to evaluate the patients who are a part of the TRIAD implementation program and assess satisfaction and decisional regret for patients with appendicitis. This information will be used to inform the design of decision-support interventions to help patients improve their ability to make an informed decision in-line with their preferences and values.
Official Title
Treatment Individualized Appendicitis Decision-Making (TRIAD) Patient Surveys
Quick Facts
Study Start:2022-10-01
Study Completion:2025-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
Kaiser Permanente Baldwin Park
Baldwin Park, California, 90027
United States
Kaiser Permanente Los Angeles
Los Angeles, California, 90027
United States
Kaiser Permanente Riverside
Riverside, California, 92555
United States
Grady Health System / Morehouse School of Medicine
Atlanta, Georgia, 30305
United States
Northwestern Medicine
Chicago, Illinois, 60611
United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
United States
Boston Medical Center
Boston, Massachusetts, 02118
United States
Michigan Medicine- University of Michigan
Ann Arbor, Michigan, 48109
United States
Columbia University Medical Center
New York, New York, 10032
United States
Atrium Health
Charlotte, North Carolina, 28204
United States
Medical University of South Carolina
Charleston, South Carolina, 29425
United States
Lyndon B Johnson- Harris Health
Houston, Texas, 77026
United States
The University of Texas Health Science Center at Houston
Houston, Texas, 77026
United States
Texas Tech University
Lubbock, Texas, 79430
United States
Harborview Medical Center
Seattle, Washington, 98104
United States
Northwest Hospital and Medical Center
Seattle, Washington, 98133
United States
University of Washington Medical Center
Seattle, Washington, 98195
United States
Collaborators and Investigators
Sponsor: University of Washington
- Giana Davidson, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Washington
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2022-10-01
Study Completion Date2025-10-01
Study Record Updates
Study Start Date2022-10-01
Study Completion Date2025-10-01
Terms related to this study
Keywords Provided by Researchers
- Decision Support Tool
- Implementation
- Antibiotics
- Surgery
Additional Relevant MeSH Terms